<DOC>
	<DOC>NCT01510912</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety of Diclofenac [Test] Capsules for the treatment of osteoarthritis pain of the knee or hip.</brief_summary>
	<brief_title>Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Male or female ≥ [greater than or equal to] 40 years of age If a participant in the previous DIC30805 study, completed the study and did not discontinue for lack of efficacy or safety Has a diagnosis of OA of the hip or knee with ongoing knee and/or articular hip pain Is a current chronic user of nonsteroidal antiinflammatory drugs (NSAIDs) and/or acetaminophen for his/her OA pain and is anticipated to benefit from continuous treatment with therapeutic doses of NSAIDs. A current chronic user is defined as a subject who has used these treatments for ≥ [greater than or equal to] 20 days of the last 30 days before screening Has a known history of allergic reaction or clinically significant intolerance to acetaminophen, aspirin, or any nonsteroid antiinflammatory drugs (NSAIDs), including diclofenac Requires chronic use of opioid or opioid combination products to control OA pain of the knee or hip Has any clinically significant unstable cardiac, respiratory, neurological, immunological, hematological, or renal disease Has significant difficulties swallowing capsules or is unable to tolerate oral medication</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>